Compound 8b

(5aR*,10bR*)-methyl 6H-5a,10b-butanobenzo[5,6][1,4]dioxino[2,3-b]indole-1-carboxylate

From: Unified biomimetic assembly of voacalgine A and bipleiophylline via divergent oxidative couplings

View in PubChem | 1H NMR | 13C NMR | MDL Molfile | ChemDraw

Compound data: CIF

Synthetic procedure: See article for the definitive version of this procedure and for full experimental details.

To a solution of 6a (60.8 mg, 0.3557 mmol) and methyl 2,3-dihydroxybenzoate 7 (125.5 mg, 0.747 mmol) in CH2Cl2 (3 mL) is added diacetate iodobenzene (229.0 mg, 0.711 mmol) at RT. The reaction mixture was stirred 15 hr and was then quenched with a saturated aqueous NaHCO3 solution. The aqueous phase was extracted twice with ethyl acetate. The combined organic phases were dried with Na2SO4, filtered and concentrated to dryness. The residue was then purified by flash chromatography over silica gel (elution gradient: pentane/ethyl acetate 90:10 80:20) affording 8a (27.0 mg, 22%) and 56 mg of a 2:1 mixture of 7 and 8b (which represents for 8b: 28 mg, 23%). 8b; IUPAC name: (5aR*,10bR*)-methyl 11H-4b,10a-butanobenzo[5,6][1,4]dioxino[2,3-b]indole-9-carboxylate. White solid, melting point: 130 °C (decomp.) Rf = 0.50 (pentane/AcOEt 80:20). IR (neat): ν max = 3346, 2946, 1720, 1617, 1466, 1274, 1195, 1144, 1021, 935, 901, 863, 752 cm–1. HRMS ESI: m/z [MH]+: 360.1196 ; calculated for C20H19NNaO4+: 360.1206. 1H NMR (360 MHz, chloroform-d), δ (ppm): 7.28 (dd, J = 7.5; 1.8 Hz, 1H), 7.21 (d, J = 7.5 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.82-6.69 (m, 4H), 4.36 (br s, 1H), 3.91 (s, 3H), 2.35 (d, J = 12.9 Hz, 1H), 2.10 (d, J = 12.9 Hz, 1H), 1.80-1.55 (m, 6H). 13C NMR (90 MHz, chloroform-d), δ (ppm): 166.5, 146.5, 144.2, 142.3, 132.6, 129.3, 123.2, 122.8, 120.7, 120.5, 120.2, 111.6, 94.5, 82.0, 52.1, 37.5, 31.3, 23.3, 20.4.